These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37119381)

  • 21. A novel cross-linking reagent for bovine hemoglobin modification.
    He M; Lu X; Zhao D; Su Z
    Biotechnol Lett; 2003 Feb; 25(4):327-30. PubMed ID: 12882546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of a microencapsulated polyethylene glycol cross-linked polyhemoglobin.
    Knirsch MC; Dell'Anno F; Chicoma D; Stephano MA; Bou-Chacra NA; Palombo D; Converti A; Polakiewicz B
    Bioprocess Biosyst Eng; 2015 Nov; 38(11):2263-9. PubMed ID: 26314399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S-nitrosylated polyethylene glycol-conjugated hemoglobin derivative as a candidate material for oxygen therapeutics.
    Nakai K; Sakuma I; Togashi H; Yoshioka M; Sugawara T; Satoh H; Kitabatake A
    Adv Exp Med Biol; 2003; 519():207-16. PubMed ID: 12675217
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of extension arm in PEG-Hb conjugates on the stability of the tetramer: non-conservative EAF maleimide thio-PEG mediated PEGylation.
    Ananda K; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):499-512. PubMed ID: 19085194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between chemical properties and biological properties of pyridoxalated hemoglobin-polyoxyethylene.
    Iwashita Y
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):299-307. PubMed ID: 1391446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoxidation of the site-specifically PEGylated hemoglobins: role of the PEG chains and the sites of PEGylation in the autoxidation.
    Hu T; Li D; Manjula BN; Acharya SA
    Biochemistry; 2008 Oct; 47(41):10981-90. PubMed ID: 18808150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemically modified porcine hemoglobins and their biological properties.
    Jin C; Wen-Fang M; Min H; Pei-Lin C; Zhong-Yi Y
    Protein Pept Lett; 2004 Aug; 11(4):353-60. PubMed ID: 15327368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extension arm facilitated pegylation of alphaalpha-hemoglobin with modifications targeted exclusively to amino groups: functional and structural advantages of free Cys-93(beta) in the PEG-Hb adduct.
    Li D; Hu T; Manjula BN; Acharya SA
    Bioconjug Chem; 2009 Nov; 20(11):2062-70. PubMed ID: 19842622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CO binding improves the structural, functional, physical and anti-oxidation properties of the PEGylated hemoglobin.
    Wang Q; Hu T; Sun L; Ji S; Zhao D; Liu J; Ma G; Su Z
    Artif Cells Nanomed Biotechnol; 2015 Feb; 43(1):18-25. PubMed ID: 24641771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemospan: design principles for a new class of oxygen therapeutic.
    Vandegriff KD; Winslow RM
    Artif Organs; 2009 Feb; 33(2):133-8. PubMed ID: 19178457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible protection of Cys-93(β) by PEG alters the structural and functional properties of the PEGylated hemoglobin.
    Wang Q; Sun L; Ji S; Zhao D; Liu J; Su Z; Hu T
    Biochim Biophys Acta; 2014 Jul; 1844(7):1201-7. PubMed ID: 24747784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new polyethyleneglycol-derivatized hemoglobin derivative with decreased oxygen affinity and limited toxicity.
    Zolog O; Mot A; Deac F; Roman A; Fischer-Fodor E; Silaghi-Dumitrescu R
    Protein J; 2011 Jan; 30(1):27-31. PubMed ID: 21161348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers.
    McCarthy MR; Vandegriff KD; Winslow RM
    Biophys Chem; 2001 Aug; 92(1-2):103-17. PubMed ID: 11527583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure, exogenous ligand binding, and redox properties of an engineered diiron active site in a bacterial hemerythrin.
    Okamoto Y; Onoda A; Sugimoto H; Takano Y; Hirota S; Kurtz DM; Shiro Y; Hayashi T
    Inorg Chem; 2013 Nov; 52(22):13014-20. PubMed ID: 24187962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering hemoglobin to enable homogenous PEGylation without modifying protein functionality.
    Cooper CE; Silkstone GGA; Simons M; Gretton S; Rajagopal BS; Allen-Baume V; Syrett N; Shaik T; Popa G; Sheng X; Bird M; Choi JW; Piano R; Ronda L; Bettati S; Paredi G; Mozzarelli A; Reeder BJ
    Biomater Sci; 2020 Jul; 8(14):3896-3906. PubMed ID: 32539053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
    Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
    Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.
    Hu J; Duppatla V; Harth S; Schmitz W; Sebald W
    Bioconjug Chem; 2010 Oct; 21(10):1762-72. PubMed ID: 20886828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivatization of haemoglobin with periodate-generated reticulation agents: evaluation of oxidative reactivity for potential blood substitutes.
    Deac F; Iacob B; Fischer-Fodor E; Damian G; Silaghi-Dumitrescu R
    J Biochem; 2011 Jan; 149(1):75-82. PubMed ID: 20961862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiolation mediated pegylation platform to generate functional universal red blood cells.
    Nacharaju P; Manjula BN; Acharya SA
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):107-18. PubMed ID: 17364475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of poly(ethylene glycol)-modified bovine hemoglobin by capillary zone electrophoresis.
    Li XZ; Yang QH; Yan JF; Xu K; Liu J; He XY; Zhang XW; Liu Q
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):1-10. PubMed ID: 17364466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.